Dr. Joy Melnikow reviews medical content for Healthwise, a nonprofit
organization with a mission to help people make better health decisions. Dr.
Melnikow is a professor in the Department of Family and Community Medicine at
the University of California Davis in Sacramento. Her teaching focuses on
problem-based learning, evidence-based medicine, and maternal child health, as
well as obstetrics and inpatient attending. In addition to teaching, Dr.
Melnikow supervises residents and research fellows, mentors junior faculty, and
provides direct outpatient and obstetric care. She also obtains grant funding
and conducts research projects for the Center for Health Services Research in
Primary Care and the UCDMC Cancer Center.
Dr. Melnikow's research interests include women's health, patient
preferences and decision-making, preventive services, cancer prevention and
early detection, and underserved populations and cost-effectiveness analysis in
women's health care.
She has served as an associate medical director for Healthwise since
1998.
Healthwise Knowledgebase Topics Reviewed
Dr. Melnikow serves as primary medical reviewer for women's
health-related topics, such as Abnormal Pap Test, Breast-Feeding, Menopause,
topics on sexually transmitted diseases, and a variety of medical test topics
related to women's health.
Professional Affiliations
Selected Publications
- Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch
S, Nuovo J (2006). Chemoprevention: Drug pricing and mortality: The case of
tamoxifen. Cancer, 107(5):
950–958.
- Kulasingam SL, Myers ER, Lawson HW, McConnell KJ,
Kerlikowske K, Melnikow J, Washington AE, Sawaya GF (2006). Cost-effectiveness
of extending cervical cancer screening intervals among women with prior normal
pap tests. Obstetrics and Gynecology, 107(2 Pt 1):
321–328.
- Sawaya GF, McConnell J, Kulasingam SL, Lawson HW,
Kerlikowske K, Melnikow J, et al. (2003). Risk of cervical dysplasia and cancer
associated with extending the interval between cervical-cancer screenings.
New England Journal of Medicine, 349(16):
1501–1509.
- Melnikow J, et al. (2003). Management of low-grade
abnormal Pap smear: What are women's preferences? Journal of Family Practice, 51(10): 849–855.
- Nuovo J, Melnikow J, Chang
D (2002). Reporting number needed to treat and absolute risk reduction in
randomized controlled trials. JAMA 282(21): 2813–2814.
Financial Disclosure
This reviewer reported no financial conflicts.